<?xml version="1.0" encoding="UTF-8"?>
<ref id="B2" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Chiou</surname>
    <given-names class="given-names">W. L.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ma</surname>
    <given-names class="given-names">C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Chung</surname>
    <given-names class="given-names">S. M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Wu</surname>
    <given-names class="given-names">T. C.</given-names>
   </name>
  </person-group> (
  <year class="year">2001</year>). 
  <article-title class="article-title">An alternative hypothesis to involvement of intestinal P-glycoprotein as the cause for digoxin oral bioavailability enhancement by talinolol.</article-title>
  <source class="source">
   <italic class="italic">Clin. Pharmacol. Ther.</italic>
  </source>
  <volume class="volume">69</volume>
  <fpage class="fpage">79</fpage>â€“
  <lpage class="lpage">81</lpage>. 
  <?supplied-pmid 11180042?>
  <pub-id pub-id-type="pmid" class="pub-id">11180042</pub-id>
 </mixed-citation>
</ref>
